Article Details
Retrieved on: 2025-07-28 19:27:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Monoclonal Antibodies, Gene and Cell Therapies, and ... The monoclonal antibodies (mAbs) segment will dominate the market through 2029.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here